PDS Biotechnology Corporation (PDSB) Financials

PDSB Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 8.8 billion 12.4 billion
March 31, 2026 24.7 million 20.8 million
Dec. 31, 2025 30.5 million 21.2 million
Sept. 30, 2025 34.7 million 25.3 million

PDSB Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -2.8 billion 2.3 billion
March 31, 2026 -4.4 billion 1.2 million
Dec. 31, 2025 -3.7 million -1.8 billion
Sept. 30, 2025 -5.9 million 1.2 million

PDSB Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
June 30, 2026 -17.1 billion
March 31, 2026 -7.3 million
Dec. 31, 2025 18.8 billion
Sept. 30, 2025 -9.0 million

PDSB Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 5.6 billion 9.5 million -
March 31, 2026 21.7 million 10.6 million 48655
Dec. 31, 2025 26.7 million 11.7 million 61853
Sept. 30, 2025 26.2 million 11.9 million 77659

PDSB Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 55.7 million
March 31, 2026 55.5 million
Dec. 31, 2025 46.4 million
Sept. 30, 2025 46.9 million

PDSB Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 4 3.3 million 3.2 million -
March 31, 2026 4 3.5 million 3.1 billion -
Dec. 31, 2025 5 4.4 million 2.3 million -
Sept. 30, 2025 - 4.6 million 3.6 million -

PDSB Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - -
March 31, 2026 - -
Dec. 31, 2025 - 15131
Sept. 30, 2025 - -

PDSB

Price: $0.21

52 week price:
0.21
1.55

Earnings Per Share: -0.64 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 392200

Market Capitalization: 12.9 million

Links: